1 / 17

What’s in a medicine?

What’s in a medicine?. Chemical Storylines. WM1 The development of modern ideas about medicine. Medicines have been used for thousands of years Examples include feverfew for migraines and willow bark for pain relief

reia
Télécharger la présentation

What’s in a medicine?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. What’s in a medicine? Chemical Storylines

  2. WM1 The development of modern ideas about medicine • Medicines have been used for thousands of years • Examples include feverfew for migraines and willow bark for pain relief • Their effectiveness was discovered by trial and error with no real scientific knowledge Key terms: • A drug alters the way your body works • A poison is simply a bad drug • Pharmacology is the study of drugs and their action

  3. WM2 Medicines from nature • Modern medicine has some of its origins in folklore and herbal remedies • The “Doctrine of Signatures” which stated that “many remedies lie not far off from their causes” and “Culpeper’s Herbal” linked diseases and cures to celestial bodies • For this reason willow bark has been used as a remedy for fever • We now know that the substance extracted from bark is converted into the active chemical in the body • WM2.1 • CI13.2 • CI13.7 • WM2.2

  4. WM3 Identifying the active chemical in willow bark • To identify the chemical structure of the extract, we need to do: • Chemical tests • Instrumental analysis • Three useful chemical tests are; • The aqueous solution is weakly acidic • Suggests a carboxylic acid group (-COOH) • It reacts with alcohols to make a fruity smelling compound • Suggests a carboxylic acid group (-COOH) • Neutral Iron (III) Chloride [FeCl3] gives a purple coloured complex • Suggests a phenol group (-OH joined to a benzene ring) • CI13.3 • CI13.4 • WM3

  5. WM4 – INSTRUMENTAL ANALYSIS • 3 important instrumental techniques are then used to help identify the structure of salicylic acid; • Infra – red (i.r.) spectroscopy • Identifies functional groups present • Mass spectrometry • Identifies fragments of the structure • Nuclear magnetic resonance (n.m.r.) spectroscopy. • Identifies different hydrogen environments present • Ass 1 • CI6.4 (revision of IR) • CI6.5 Mass Spectrometry • WM4 “Using Spectroscopy”

  6. Infra–red (i.r.) spectroscopy An i.r. spectrum provides information about which functional groups are present by the characteristic absorptions of their bonds. Here is the infra – red spectrum of salicylic acid O-H in carboxylic acid Aromatic C-H bonds C=O in carboxylic acid Phenolic O-H

  7. N.m.r. spectroscopy • Nuclear Magnetic Resonance (n.m.r.) spectroscopy identifies the different chemical environments which hydrogen nuclei (“protons”) exist in in a molecule. • For salicylic acid there are 3 different environments for H nuclei…. • 1 proton in a COOH environment. • 1 proton in a phenolic –OH environment. • 4 protons attached to a benzene ring. • so we should see three peaks…..!

  8. The Mass Spectrum of salicylic acid • Used to determine more details about the structure of molecule • Helps identify which isomer of a substance is present. • Each peak corresponds to a positively charged ion which comes from the parent molecule after it has broken into fragments. • The highest mass peak is for the molecular ion and tells you the Mr • This helps to confirm that the molecular formula is C7H6O3. • The other peaks are produced as the molecule is broken up. • This “fragmentation pattern” is characteristic of the compound and the molecule can therefore be identified.

  9. Drawing the evidence together • Chemical Tests: • presence of a phenolic –OH group and a carboxylic acid group (-COOH) • IR spectroscopy: • presence of –O-H and –C=O bonds. • NMR spectroscopy: • H atoms in 3 different environments; • - OH • -COOH • - 4 attached to a benzene ring • Mass spectroscopy: • Salicylic acid is 2-hydroxybenzoic acid……

  10. WM5 – THE SYNTHESIS OF SALICYLIC ACID AND ASPIRIN • A medicine from natural sources is not ideal • Supply may be seasonal • It may be affected by weather, disease, etc.. • It is not environmentally sound • Artificial production, or synthesis is far more reliable. • This is not a simple task • Larger, more complex molecules cannot simply be made from their elements. • A startingmaterial is needed which can be readily converted by introducing the active functional groups onto a molecule without disrupting its overall structure.

  11. In the late 19th century Felix Hofmann developed a method for making 2-hydroxybenzoic acid industrially • This combined carbon dioxide with phenol. (Known as the Kolbe synthesis) • This has no bi-products and so has 100% atom economy • CI15.8 “Atom economy” • 2-hydroxybenzoic acid became commonly used as a medicine to cure fevers and suppress pain. • However, reports of side effects began to be reported. • Modification of the structure became necessary to reduce the irritating side effects, yet retain the beneficial ones. • CI13.5 Esters • WM5.1 Preparation of Aspirin • see CI 7.3 and CI Appendix 1:experimental techniques • WM5.3 Reaction type and atom economy

  12. Hofmann prepared a range of related compounds • All with slightly modified structures • He tried out each one on his father! • In 1898, an effective derivative was found… • …an ester of 2-hydroxybenzoic acid called 2-ethanoyl hydroxybenzoic acid. • It is made by reacting 2-hydroxybenzoic acid with ethanoyl chloride or ethanoic anhydride in an ACYLATION reaction • This was given the name ASPIRIN. Ethanoyl group (an ACYL group)

  13. WM6 Delivering the Product • Developing a new medicine costs an enormous amount of money • Patents ensure other companies can’t copy the medicine for a certain amount of time • Once the patents have lapsed anybody can produce and market the drug, • The company must charge enough during the period of the patent to recover their development, marketing and production costs • Most pharmaceuticals will have three names; • Chemical name (often very long and complicated) • Generic name (shorter name for the chemical) • Brand name (to market it under) • For example; • 2-(4-(2-methylpropyl)-phenyl) propanoic acid • Ibuprofen • Nurofen

  14. The Safety of Aspirin • Manufacturers need to be able to analyse samples to ensure they contain the correct amount of active chemical • Hospitals need to be able identify chemicals and the quantities they are in. • WM6 “Aspirin Assay” • CI8.1 “Acids and Bases” • Like all medicines, aspirin is only safe if taken in the recommended dose • The lethal dose for and adult is about 30g (100 tablets)

  15. WM7 – THE MIRACULOUS MEDICINE • 50 billion aspirin tablets are consumed in the UK each year! • It has a range of uses; • Headaches and as a general painkiller. • Arthritis • To avoid heart disease • To prevent blood clotting and help in the treatment of strokes. • Aspirin is over 100 years old and it has never been replaced, indeed new uses for aspirin are still being researched and developed.

  16. WM8 – DEVELOPMENT AND SAFETY TESTING OF MEDICINES • Development and safety testing of a new drug can take 10-15 years and cost up to £350 million. The stages involved are; • Research • Development of synthesis methods. • Testing for; • Toxicity • Effectiveness • Side effects • Evaluation of data so far. • Modifications if necessary • Further testing until all criteria met. • Trials on patients. • License applications to market product. • Patent applications to protect investments. • Launch of drug!! • At each stage the financial implications of the drug, its market and potential profit margins must be taken into consideration.

  17. Lead compound Lead compound

More Related